Copyright Reports & Markets. All rights reserved.

Global Substance Abuse Therapeutics Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Substance Abuse Therapeutics Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Substance Abuse Therapeutics Market Size 2014-2024
        • 2.1.2 Substance Abuse Therapeutics Market Size CAGR by Region
      • 2.2 Substance Abuse Therapeutics Segment by Type
        • 2.2.1 Opioid Addiction
        • 2.2.2 Tobacco/Nicotine Addiction
        • 2.2.3 Alcohol Dependence
      • 2.3 Substance Abuse Therapeutics Market Size by Type
        • 2.3.1 Global Substance Abuse Therapeutics Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Substance Abuse Therapeutics Market Size Growth Rate by Type (2014-2019)
      • 2.4 Substance Abuse Therapeutics Segment by Application
        • 2.4.1 Hospital & Clinics
        • 2.4.2 Residential (non-hospital)
      • 2.5 Substance Abuse Therapeutics Market Size by Application
        • 2.5.1 Global Substance Abuse Therapeutics Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Substance Abuse Therapeutics Market Size Growth Rate by Application (2014-2019)

      3 Global Substance Abuse Therapeutics by Players

      • 3.1 Global Substance Abuse Therapeutics Market Size Market Share by Players
        • 3.1.1 Global Substance Abuse Therapeutics Market Size by Players (2017-2019)
        • 3.1.2 Global Substance Abuse Therapeutics Market Size Market Share by Players (2017-2019)
      • 3.2 Global Substance Abuse Therapeutics Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Substance Abuse Therapeutics by Regions

      • 4.1 Substance Abuse Therapeutics Market Size by Regions
      • 4.2 Americas Substance Abuse Therapeutics Market Size Growth
      • 4.3 APAC Substance Abuse Therapeutics Market Size Growth
      • 4.4 Europe Substance Abuse Therapeutics Market Size Growth
      • 4.5 Middle East & Africa Substance Abuse Therapeutics Market Size Growth

      5 Americas

      • 5.1 Americas Substance Abuse Therapeutics Market Size by Countries
      • 5.2 Americas Substance Abuse Therapeutics Market Size by Type
      • 5.3 Americas Substance Abuse Therapeutics Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Substance Abuse Therapeutics Market Size by Countries
      • 6.2 APAC Substance Abuse Therapeutics Market Size by Type
      • 6.3 APAC Substance Abuse Therapeutics Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Substance Abuse Therapeutics by Countries
      • 7.2 Europe Substance Abuse Therapeutics Market Size by Type
      • 7.3 Europe Substance Abuse Therapeutics Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Substance Abuse Therapeutics by Countries
      • 8.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Type
      • 8.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Substance Abuse Therapeutics Market Forecast

      • 10.1 Global Substance Abuse Therapeutics Market Size Forecast (2019-2024)
      • 10.2 Global Substance Abuse Therapeutics Forecast by Regions
        • 10.2.1 Global Substance Abuse Therapeutics Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Substance Abuse Therapeutics Forecast by Type
      • 10.8 Global Substance Abuse Therapeutics Forecast by Application

      11 Key Players Analysis

      • 11.1 Indivior
        • 11.1.1 Company Details
        • 11.1.2 Substance Abuse Therapeutics Product Offered
        • 11.1.3 Indivior Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Indivior News
      • 11.2 Pfizer
        • 11.2.1 Company Details
        • 11.2.2 Substance Abuse Therapeutics Product Offered
        • 11.2.3 Pfizer Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Pfizer News
      • 11.3 Alkermes
        • 11.3.1 Company Details
        • 11.3.2 Substance Abuse Therapeutics Product Offered
        • 11.3.3 Alkermes Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Alkermes News
      • 11.4 Novartis
        • 11.4.1 Company Details
        • 11.4.2 Substance Abuse Therapeutics Product Offered
        • 11.4.3 Novartis Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Novartis News
      • 11.5 Mylan
        • 11.5.1 Company Details
        • 11.5.2 Substance Abuse Therapeutics Product Offered
        • 11.5.3 Mylan Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Mylan News
      • 11.6 Cipla
        • 11.6.1 Company Details
        • 11.6.2 Substance Abuse Therapeutics Product Offered
        • 11.6.3 Cipla Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Cipla News
      • 11.7 Glenmark
        • 11.7.1 Company Details
        • 11.7.2 Substance Abuse Therapeutics Product Offered
        • 11.7.3 Glenmark Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Glenmark News
      • 11.8 Dr. Reddy's Laboratories
        • 11.8.1 Company Details
        • 11.8.2 Substance Abuse Therapeutics Product Offered
        • 11.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Dr. Reddy's Laboratories News
      • 11.9 Teva Pharmaceutical
        • 11.9.1 Company Details
        • 11.9.2 Substance Abuse Therapeutics Product Offered
        • 11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Teva Pharmaceutical News

      12 Research Findings and Conclusion

      Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

      According to this study, over the next five years the Substance Abuse Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Substance Abuse Therapeutics business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Substance Abuse Therapeutics market by product type, application, key companies and key regions.

      This study considers the Substance Abuse Therapeutics value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Opioid Addiction
      Tobacco/Nicotine Addiction
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Hospital & Clinics
      Residential (non-hospital)

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Indivior
      Pfizer
      Alkermes
      Novartis
      Mylan
      Cipla
      Glenmark
      Dr. Reddy's Laboratories
      Teva Pharmaceutical

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Substance Abuse Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Substance Abuse Therapeutics market by identifying its various subsegments.
      Focuses on the key global Substance Abuse Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Substance Abuse Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Substance Abuse Therapeutics submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now